The Company is suspending previous guidance related to Booked SaaS ACV and anticipates providing updates on future expectations in conjunction with the release of its fiscal third quarter 2023 financial results.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on STRM:
- Streamline Health announces new RevID contract with Georgia healthcare provider
- Streamline Health price target lowered to $2 from $3 at Lake Street
- Streamline Health reports Q2 EPS (4c), consensus (5c)
- Streamline Health® Reports Fiscal Second Quarter Financial Results
- STRM Earnings Report this Week: Is It a Buy, Ahead of Earnings?